Chris-B.png

About Mountaineer Chris Bombardier

  • Founder of www.AdventuresofaHemophiliac.com.
  • Has severe hemophilia B.
  • Has summited five of the world’s Seven Summits.
  • His first summit was Mt. Kilimanjaro.
  • Board member, Save One Life, an international hemophilia nonprofit.
  • Founder, Backpacks & Bleeders, an outdoor adventure organization for people with bleeding disorders.
  • Founder, #playitsmart Initiative.
  • Volunteer, Colorado Chapter, National Hemophilia Foundation.
  • Currently an adventure educator for GutMonkey.
  • First person with hemophilia to summit Aconcagua, Mt. Elbrus, Denali and Carstensz Pyramid. 

Patrick-James-Lynch.jpg

About Director Patrick James Lynch

  • Has severe hemophilia A.
  • Co-founder & CEO of Believe Limited, a digital content agency and production company.
  • Founding board president of the 501(c)(3) Entertainment 2 Affect Change.
  • Creator, executive producer and star of award-winning bleeding disorders web series Stop The Bleeding!
  • Director of the World Federation of Hemophilia's Treatment for All web series.
  • Host and executive producer of The BloodStream Podcast.
  • 2013 Recipient of the Hemophilia Federation of America's Health & Wellness Award.
  • 2014 Recipient of the National Hemophilia Foundation's Meritorious Achievement Award.
  • 2016 Plenary Speaker for World Federation of Hemophilia's World Congress. 

Laurie High-Res.jpeg

About Laurie Kelley

  • President of LA Kelley Communications, Inc.
  • Founder and president of Save One Life, Inc.
  • Author of eleven books on hemophilia, including Raising a Child with Hemophilia.
  • Founder and publisher of the Parent Empowerment Newsletter.
  • Founder of HemaBlog.
  • Founder of Project SHARE, which donates life-saving medicine to people with hemophilia worldwide.
  • Helped establish hemophilia nonprofits in seven developing countries.
  • Global coach for leaders in developing countries, to start and develop hemophilia nonprofits.
  • Has visited 29 developing countries to work with hemophilia patients and nonprofits.
  • Has worked with hemophilia in developing countries for 20 years. 

Filmmaking Team

The filmmaking team, from left to right:

  • Josh Bragg, Cinematographer
  • Rob Bradford, Producer & Climber
  • Carl Trenz, Director of Therapy Development, Octapharma
  • Chris Bombardier, Mountaineer
  • Patrick James Lynch, Director/Producer
  • David Beede, Sound Mixer 

Octa Logo for Filmmakers Page.png

About Octapharma

  • For more than 30 years, Octapharma has been focused exclusively on the development and manu- facture of high-quality human proteins for use as medical treatments.
  • Patients in more than 100 countries are treated with Octapharma therapies for serious chronic and genetic disorders in hematology, immunotherapy and critical care.
  • Headquartered in Lachen, Switzerland, Octapharma continuously develops sophisticated technolo- gies to help improve the safety of human protein products for patients.
  • The company’s American subsidiary, Octapharma USA, located in Hoboken, New Jersey, last year introduced NUWIQ®, Antihemophilic Factor (Recombinant) to the U.S. bleeding disorders community.
  • Octapharma’s commitment to patients also is evident in its product for von Willebrand Disease (VWD) patients – WILATE®, von Willebrand Factor/Coagulation Factor VIII Complex (Human).
  • Octapharma was the first company to apply the solvent/detergent virus inactivation process to the routine production of Factor VIII concentrates vital to the bleeding disorders community.
  • Octapharma operates 80 plasma collection centers in the U.S. and Germany, as well as a new state-of-the-art testing laboratory in Charlotte, North Carolina.
  • The company’s global presence includes more than 6,200 employees, 32 international locations, six production facilities, and five research and development centers.